M Holdings Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,116
Closed -$438K 233
2024
Q2
$438K Buy
+4,116
New +$413K 0.06% 183
2023
Q2
Sell
-5,705
Closed -$525K 376
2023
Q1
$525K Buy
5,705
+395
+7% +$34.5K 0.05% 252
2022
Q4
$482K Sell
5,310
-22
-0.4% -$1.85K 0.05% 256
2022
Q3
$405K Hold
5,332
0.04% 275
2022
Q2
$451K Sell
5,332
-474
-8% -$41.6K 0.05% 266
2022
Q1
$509K Buy
+5,806
New +$503K 0.04% 293
2021
Q2
Sell
-5,767
Closed -$493K 392
2021
Q1
$493K Buy
+5,767
New +$518K 0.04% 293
2019
Q2
Sell
-3,300
Closed -$284K 295
2019
Q1
$284K Buy
+3,300
New +$265K 0.07% 285
2018
Q4
Sell
-3,644
Closed -$281K 352
2018
Q3
$281K Sell
3,644
-6,786
-65% -$502K 0.07% 276
2018
Q2
$706K Buy
+10,430
New +$720K 0.19% 148
2016
Q3
Sell
-3,073
Closed -$227K 264
2016
Q2
$227K Buy
+3,073
New +$212K 0.12% 213
2014
Q4
Sell
-1,915
Closed -$162K 350
2014
Q3
$162K Buy
+1,915
New +$155K 0.09% 212
2014
Q1
Sell
-3,037
Closed -$219K 186
2013
Q4
$219K Buy
+3,037
New +$211K 0.16% 149

Other funds holding NVS

M Holdings Securities's NVS Position: Q3 2024 in Review

M Holdings Securities sold out of Novartis (NVS) in Q3 2024, closing a stake of 4,116 shares — an estimated $438K sold.

M Holdings Securities first reported a position in NVS in Q4 2013 and held it in 13 quarters. The position peaked at $706K in Q2 2018. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • M Holdings Securities reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
  • M Holdings Securities sold 4,116 Novartis shares in Q3 2024, an estimated $438K.
  • M Holdings Securities first reported a position in Novartis in Q4 2013 and held it in 13 quarters.
  • M Holdings Securities's Novartis position peaked at $706K in Q2 2018.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on M Holdings Securities's 13F filing for Q3 2024, filed 12 Nov 2024.